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INTRODUCTION
Lehigh Valley Health Network, Allentown, Pennsylvania
Diffuse large B-cell lymphomas (DLBCL) positive for immunohistochemical marker CD5 are 
uncommon, non-Hodgkin lymphomas that can rarely present with profound encephalopathy and 
offer affected patients unfortunately poor prognoses. Deterioration within two weeks though is 
unlikely. The author postulates the possibility of a subacute, untreated varicella zoster infection as 
the etiology of a PCR-negative zoster encephalitis that precipitated this patient’s decline due to 
incidental immunocompromise.
1.  The patient visited her PCP 3 months prior to her presentation to the hospital, complaining of LLQ abdominal pain of one month duration. 
Uncomplicated shingles was diagnosed, of one dermatome, and Valacyclovir was prescribed though never taken. She elected to treat 
symptoms with Neurontin and Aleve. She was seen by her PCP for follow up 6 weeks later with near resolution of the shingles infection.
CASE REPORT
A 66-year-old female with a history of hypothyroidism and subacute resolution of an untreated 
herpes zoster infection1 presented with a one month history of encephalopathy, lightheadedness, 
nighttime fevers and fatigue. She was febrile, hypotensive and tachycardic, with pallor and a mildly 
tender abdomen. Mental status exam revealed disorientation, inconsistent command following, 
inattention, perseveration, confabulations and 6/30 on the Montreal Cognitive Assessment. Imaging 
demonstrated splenomegaly and mesenteric lymphadenopathy concerning for lymphoma. Brain 
MRI revealed T2 hyperintensity in the left temporal lobe with suspected internal hemorrhage on 
susceptibility weighted imaging. Lab studies showed pancytopenia, elevated inflammatory markers, 
and significantly elevated LDH.  CSF studies revealed elevated protein and RBCs with normal glucose, 
though PCR for VZV was negative. CSF PCR sensitivity for varicella is only 80%. Cytology on CSF was 
negative, but this test has an even lower sensitivity. Paraneoplastic antibodies were checked and 
negative. By day 11 the patient became hemodynamically unstable and developed multiple organ 
failure. Exploratory laparotomy performed for suspected ischemic colitis instead revealed bulky 
mesenteric lymphadenopathy obstructing the small bowel, which was resected and biopsied. The 
patient further deteriorated and the family withdrew care soon after. Lymph node biopsy revealed 
aggressive CD5+ DLBCL, activated-B-cell-like. Autopsy and brain biopsy were not performed. 
DISCUSSION
We do not know what provoked this patient’s multi-organ failure and rapid deterioration. DLBCLs 
rarely present with encephalopathy and CD5+ DLBCLs, though notoriously aggressive, do not by 
themselves precipitate such rapid deterioration. Herpes zoster encephalitis can cause rapid decline 
but is a rare diagnosis in the presence of “sterile” CSF and unilateral temporal lobe findings. The 
author suspects CD5+ DLBCL caused immune compromise such that herpes zoster encephalitis 
instigated a rapidly fatal outcome in this patient. The case illustrates rare presentations of two 
coinciding diseases. Additionally it emphasizes the paramount need for a thorough history of pre-
admission events and for broad, empiric coverage of patients even in the face of negative or 
uncharacteristic evidence. Yes, this patient was found, post-mortem, to have a famously aggressive 
DLBCL of the abdomen, but she presented with encephalopathy. And, when all of the pieces do not 
fit the clinical presentation, other factors need to be considered. Given the presentation and the 
above date there is room to believe that aggressive antiviral treatment may have changed the clinical 
course of this patient. 
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